Quest for the right Drug

|
עמוד הבית / פרולוטקס / מידע מעלון לרופא

פרולוטקס PROLUTEX (PROGESTERONE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

תוך-שרירי, תת-עורי : I.M, S.C

צורת מינון:

תמיסה להזרקה : SOLUTION FOR INJECTION

Special Warning : אזהרת שימוש

4.4 Special warnings and precautions for use

Prolutex should be discontinued if any of the following conditions are suspected: myocardial infarction, cerebrovascular disorders, arterial or venous thromboembolism, thrombophlebitis, or retinal thrombosis.
Caution is indicated in patients with mild to moderate hepatic dysfunction.
Caution is indicated in patients with moderate to severe renal dysfunction, because accumulation of cyclodextrins may occur.
Patients with a history of depression need to be closely observed. Consider discontinuation if symptoms worsen.
Because progesterone may cause some degree of fluid retention, conditions that might be influenced by this factor (e.g. epilepsy, migraine, asthma, cardiac or renal dysfunction) require careful observation.
A decrease in insulin sensitivity and thereby in glucose tolerance has been observed in a small number of patients on oestrogen-progestogen combination drugs. The mechanism of this decrease is not known. For this reason, diabetic patients should be carefully observed while receiving progesterone therapy (see section 4.5).
Sex steroid use may also increase the risk of retinal vascular lesions. To prevent these latter complications, caution is to be taken in users >35 years, in smokers, and in those with risk factors for atherosclerosis. Use should be terminated in case of transient ischemic events, appearance of sudden severe headaches, or vision impairments related to papillary oedema or retinal haemorrhage.
Abrupt discontinuation of progesterone dosing may cause increased anxiety, moodiness, and increased sensibility to seizures.
Before starting treatment with Prolutex, the patient and her partner should be assessed by a doctor for causes of infertility or pregnancy complications.

Effects on Driving

4.7 Effects on ability to drive and use machines
Prolutex has minor or moderate influence on the ability to drive and use machines. Progesterone may cause drowsiness and/or dizziness; therefore caution is advised in drivers and those operating machinery.


שימוש לפי פנקס קופ''ח כללית 1994 Dysfunctional uterine bleeding, habitual & theatened abortion, in vitro fertilization (IVF), gamete intra-fallopian transfer (GIFT)
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה שאושרה לשימוש כללי בקופ'ח

בעל רישום

CTS LTD

רישום

175 15 37196 99

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

26.03.24 - עלון לרופא

עלון מידע לצרכן

26.03.24 - עלון לצרכן אנגלית 26.03.24 - עלון לצרכן עברית 26.03.24 - עלון לצרכן ערבית

לתרופה במאגר משרד הבריאות

פרולוטקס

קישורים נוספים

RxList WebMD Drugs.com